Lixte Biotechnology Holdings Inc (LIXT)
2.95
+0.06
(+2.08%)
USD |
NASDAQ |
May 06, 16:00
2.95
0.00 (0.00%)
After-Hours: 17:37
Lixte Biotechnology Holdings Max Drawdown (5Y): 97.86% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 97.86% |
| March 31, 2024 | 97.86% |
| February 29, 2024 | 97.86% |
| January 31, 2024 | 97.86% |
| December 31, 2023 | 97.84% |
| November 30, 2023 | 97.84% |
| October 31, 2023 | 97.84% |
| September 30, 2023 | 97.84% |
| August 31, 2023 | 97.16% |
| July 31, 2023 | 95.73% |
| June 30, 2023 | 94.14% |
| May 31, 2023 | 94.13% |
| April 30, 2023 | 94.13% |
| March 31, 2023 | 94.13% |
| February 28, 2023 | 94.13% |
| January 31, 2023 | 94.13% |
| December 31, 2022 | 94.13% |
| November 30, 2022 | 94.07% |
| October 31, 2022 | 93.83% |
| September 30, 2022 | 93.83% |
| August 31, 2022 | 91.34% |
| July 31, 2022 | 91.34% |
| June 30, 2022 | 91.34% |
| May 31, 2022 | 90.73% |
| April 30, 2022 | 87.30% |
| Date | Value |
|---|---|
| March 31, 2022 | 87.30% |
| February 28, 2022 | 87.30% |
| January 31, 2022 | 87.30% |
| December 31, 2021 | 87.30% |
| November 30, 2021 | 89.88% |
| October 31, 2021 | 89.88% |
| September 30, 2021 | 89.88% |
| August 31, 2021 | 89.88% |
| July 31, 2021 | 89.88% |
| June 30, 2021 | 89.88% |
| May 31, 2021 | 89.88% |
| April 30, 2021 | 89.88% |
| March 31, 2021 | 89.88% |
| February 28, 2021 | 89.88% |
| January 31, 2021 | 89.88% |
| December 31, 2020 | 89.88% |
| November 30, 2020 | 89.88% |
| October 31, 2020 | 89.88% |
| September 30, 2020 | 89.88% |
| August 31, 2020 | 89.88% |
| July 31, 2020 | 89.88% |
| June 30, 2020 | 89.88% |
| May 31, 2020 | 89.88% |
| April 30, 2020 | 89.88% |
| March 31, 2020 | 89.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
87.30%
Minimum
Dec 2021
97.86%
Maximum
Jan 2024
91.73%
Average
89.88%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| iBio Inc | 99.97% |
| PAVmed Inc | 98.81% |
| PDS Biotechnology Corp | 99.86% |
| Moleculin Biotech Inc | 97.86% |
| Syros Pharmaceuticals Inc | 98.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -44.57 |
| Beta (5Y) | -0.2291 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.08% |
| Historical Sharpe Ratio (5Y) | -0.5411 |
| Historical Sortino (5Y) | -1.049 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.77% |